CHRISTY VOGEL: Open Payments
NPI 1881360667 · SEYMOUR, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,349 in 81 payments from 13 companies in 2025. Trend: 2023 $62 · 2024 $494 · 2025 $1,349
Food & beverage: $1,329Education: $20
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $364 |
| Vanda Pharmaceuticals Inc. | 20 | $310 |
| Alkermes, Inc. | 15 | $264 |
| Collegium Pharmaceutical, Inc. | 4 | $84 |
| E.R. Squibb & Sons, L.L.C. | 5 | $78 |
| Otsuka America Pharmaceutical, Inc. | 4 | $67 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $40 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Corium, LLC | 1 | $21 |
Products named: VRAYLAR, FANAPT, ARISTADA, REXULTI, Jornay PM, COBENFY, CAPLYTA, TRINTELLIX.
Industry payments across IN — which companies pay providers there.
